nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ABCB1—Lisinopril—systemic scleroderma	0.0823	0.189	CbGbCtD
Trazodone—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0745	0.171	CbGbCtD
Trazodone—ABCB1—Captopril—systemic scleroderma	0.0616	0.141	CbGbCtD
Trazodone—CYP2D6—Captopril—systemic scleroderma	0.058	0.133	CbGbCtD
Trazodone—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0485	0.111	CbGbCtD
Trazodone—HTR2B—cardial valve—systemic scleroderma	0.0389	0.383	CbGeAlD
Trazodone—ABCB1—Prednisone—systemic scleroderma	0.0388	0.089	CbGbCtD
Trazodone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0291	0.0667	CbGbCtD
Trazodone—CYP3A4—Prednisone—systemic scleroderma	0.0232	0.0533	CbGbCtD
Trazodone—ABCB1—Methotrexate—systemic scleroderma	0.0195	0.0447	CbGbCtD
Trazodone—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0119	0.117	CbGeAlD
Trazodone—HTR2A—pulmonary artery—systemic scleroderma	0.00841	0.0828	CbGeAlD
Trazodone—HTR2A—artery—systemic scleroderma	0.00312	0.0307	CbGeAlD
Trazodone—HTR2A—endothelium—systemic scleroderma	0.00263	0.0259	CbGeAlD
Trazodone—HTR2A—blood vessel—systemic scleroderma	0.00243	0.0239	CbGeAlD
Trazodone—HTR2B—smooth muscle tissue—systemic scleroderma	0.00213	0.021	CbGeAlD
Trazodone—HTR2B—skin of body—systemic scleroderma	0.00211	0.0207	CbGeAlD
Trazodone—SLC6A4—digestive system—systemic scleroderma	0.0017	0.0167	CbGeAlD
Trazodone—HTR2B—digestive system—systemic scleroderma	0.00168	0.0166	CbGeAlD
Trazodone—ORM1—lung—systemic scleroderma	0.00167	0.0164	CbGeAlD
Trazodone—HTR2B—tendon—systemic scleroderma	0.0016	0.0158	CbGeAlD
Trazodone—ABCB1—blood vessel—systemic scleroderma	0.00159	0.0157	CbGeAlD
Trazodone—HRH1—connective tissue—systemic scleroderma	0.00149	0.0147	CbGeAlD
Trazodone—ADRA2A—connective tissue—systemic scleroderma	0.00146	0.0144	CbGeAlD
Trazodone—SLC6A4—lung—systemic scleroderma	0.00142	0.014	CbGeAlD
Trazodone—HTR2B—lung—systemic scleroderma	0.00141	0.0138	CbGeAlD
Trazodone—HRH1—smooth muscle tissue—systemic scleroderma	0.00136	0.0134	CbGeAlD
Trazodone—HTR2A—connective tissue—systemic scleroderma	0.00124	0.0123	CbGeAlD
Trazodone—HTR2A—smooth muscle tissue—systemic scleroderma	0.00114	0.0112	CbGeAlD
Trazodone—CYP3A5—digestive system—systemic scleroderma	0.00111	0.0109	CbGeAlD
Trazodone—HRH1—digestive system—systemic scleroderma	0.00108	0.0106	CbGeAlD
Trazodone—HRH1—tendon—systemic scleroderma	0.00102	0.0101	CbGeAlD
Trazodone—ADRA2A—tendon—systemic scleroderma	0.00101	0.00991	CbGeAlD
Trazodone—CYP3A5—lung—systemic scleroderma	0.000926	0.00912	CbGeAlD
Trazodone—HTR2A—digestive system—systemic scleroderma	0.000899	0.00886	CbGeAlD
Trazodone—HRH1—lung—systemic scleroderma	0.000899	0.00886	CbGeAlD
Trazodone—ADRA2A—lung—systemic scleroderma	0.000883	0.0087	CbGeAlD
Trazodone—HTR2A—tendon—systemic scleroderma	0.000856	0.00843	CbGeAlD
Trazodone—CYP3A4—digestive system—systemic scleroderma	0.000832	0.0082	CbGeAlD
Trazodone—CYP2D6—digestive system—systemic scleroderma	0.000819	0.00807	CbGeAlD
Trazodone—HTR2A—lung—systemic scleroderma	0.000751	0.0074	CbGeAlD
Trazodone—ABCB1—digestive system—systemic scleroderma	0.000589	0.0058	CbGeAlD
Trazodone—Anxiety—Lisinopril—systemic scleroderma	0.000494	0.00107	CcSEcCtD
Trazodone—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000494	0.00107	CcSEcCtD
Trazodone—Dyspnoea—Leflunomide—systemic scleroderma	0.000493	0.00107	CcSEcCtD
Trazodone—Hypotension—Mycophenolic acid—systemic scleroderma	0.000493	0.00107	CcSEcCtD
Trazodone—ABCB1—lung—systemic scleroderma	0.000492	0.00485	CbGeAlD
Trazodone—Discomfort—Lisinopril—systemic scleroderma	0.00049	0.00106	CcSEcCtD
Trazodone—Lethargy—Methotrexate—systemic scleroderma	0.00049	0.00106	CcSEcCtD
Trazodone—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.00049	0.00106	CcSEcCtD
Trazodone—Vomiting—Mometasone—systemic scleroderma	0.000486	0.00105	CcSEcCtD
Trazodone—Dry mouth—Lisinopril—systemic scleroderma	0.000485	0.00105	CcSEcCtD
Trazodone—Feeling abnormal—Azathioprine—systemic scleroderma	0.000483	0.00104	CcSEcCtD
Trazodone—Rash—Mometasone—systemic scleroderma	0.000482	0.00104	CcSEcCtD
Trazodone—Asthenia—Captopril—systemic scleroderma	0.000482	0.00104	CcSEcCtD
Trazodone—Dermatitis—Mometasone—systemic scleroderma	0.000482	0.00104	CcSEcCtD
Trazodone—Decreased appetite—Leflunomide—systemic scleroderma	0.000481	0.00104	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000481	0.00104	CcSEcCtD
Trazodone—Confusional state—Lisinopril—systemic scleroderma	0.000479	0.00104	CcSEcCtD
Trazodone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000479	0.00103	CcSEcCtD
Trazodone—Headache—Mometasone—systemic scleroderma	0.000479	0.00103	CcSEcCtD
Trazodone—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000478	0.00103	CcSEcCtD
Trazodone—Insomnia—Mycophenolic acid—systemic scleroderma	0.000477	0.00103	CcSEcCtD
Trazodone—Fatigue—Leflunomide—systemic scleroderma	0.000477	0.00103	CcSEcCtD
Trazodone—Oedema—Lisinopril—systemic scleroderma	0.000475	0.00103	CcSEcCtD
Trazodone—Pruritus—Captopril—systemic scleroderma	0.000475	0.00103	CcSEcCtD
Trazodone—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000474	0.00102	CcSEcCtD
Trazodone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000474	0.00102	CcSEcCtD
Trazodone—Pain—Leflunomide—systemic scleroderma	0.000473	0.00102	CcSEcCtD
Trazodone—Constipation—Leflunomide—systemic scleroderma	0.000473	0.00102	CcSEcCtD
Trazodone—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00102	CcSEcCtD
Trazodone—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000471	0.00102	CcSEcCtD
Trazodone—Somnolence—Mycophenolic acid—systemic scleroderma	0.000469	0.00101	CcSEcCtD
Trazodone—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000469	0.00101	CcSEcCtD
Trazodone—Shock—Lisinopril—systemic scleroderma	0.000468	0.00101	CcSEcCtD
Trazodone—Tachycardia—Lisinopril—systemic scleroderma	0.000464	0.001	CcSEcCtD
Trazodone—Abdominal pain—Azathioprine—systemic scleroderma	0.000463	0.001	CcSEcCtD
Trazodone—Body temperature increased—Azathioprine—systemic scleroderma	0.000463	0.001	CcSEcCtD
Trazodone—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00046	0.000994	CcSEcCtD
Trazodone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00046	0.000993	CcSEcCtD
Trazodone—Diarrhoea—Captopril—systemic scleroderma	0.000459	0.000992	CcSEcCtD
Trazodone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000459	0.000991	CcSEcCtD
Trazodone—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000459	0.000991	CcSEcCtD
Trazodone—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000458	0.000989	CcSEcCtD
Trazodone—Erectile dysfunction—Prednisone—systemic scleroderma	0.000457	0.000988	CcSEcCtD
Trazodone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000456	0.000985	CcSEcCtD
Trazodone—Fatigue—Mycophenolic acid—systemic scleroderma	0.000455	0.000983	CcSEcCtD
Trazodone—Nausea—Mometasone—systemic scleroderma	0.000454	0.000981	CcSEcCtD
Trazodone—Anorexia—Lisinopril—systemic scleroderma	0.000453	0.000979	CcSEcCtD
Trazodone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000453	0.000977	CcSEcCtD
Trazodone—Weight increased—Prednisone—systemic scleroderma	0.000452	0.000976	CcSEcCtD
Trazodone—Ataxia—Methotrexate—systemic scleroderma	0.000452	0.000975	CcSEcCtD
Trazodone—Pain—Mycophenolic acid—systemic scleroderma	0.000451	0.000975	CcSEcCtD
Trazodone—Constipation—Mycophenolic acid—systemic scleroderma	0.000451	0.000975	CcSEcCtD
Trazodone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000451	0.000974	CcSEcCtD
Trazodone—Weight decreased—Prednisone—systemic scleroderma	0.000449	0.00097	CcSEcCtD
Trazodone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000969	CcSEcCtD
Trazodone—Hypotension—Lisinopril—systemic scleroderma	0.000444	0.00096	CcSEcCtD
Trazodone—Dizziness—Captopril—systemic scleroderma	0.000444	0.000959	CcSEcCtD
Trazodone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000441	0.000952	CcSEcCtD
Trazodone—Urticaria—Leflunomide—systemic scleroderma	0.00044	0.00095	CcSEcCtD
Trazodone—Abdominal pain—Leflunomide—systemic scleroderma	0.000437	0.000945	CcSEcCtD
Trazodone—Body temperature increased—Leflunomide—systemic scleroderma	0.000437	0.000945	CcSEcCtD
Trazodone—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000436	0.000943	CcSEcCtD
Trazodone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000435	0.00094	CcSEcCtD
Trazodone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000939	CcSEcCtD
Trazodone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000939	CcSEcCtD
Trazodone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000939	CcSEcCtD
Trazodone—Myocardial infarction—Prednisone—systemic scleroderma	0.000434	0.000937	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000433	0.000936	CcSEcCtD
Trazodone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000433	0.000935	CcSEcCtD
Trazodone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000432	0.000932	CcSEcCtD
Trazodone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000432	0.000932	CcSEcCtD
Trazodone—Insomnia—Lisinopril—systemic scleroderma	0.00043	0.000929	CcSEcCtD
Trazodone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000429	0.000927	CcSEcCtD
Trazodone—Paraesthesia—Lisinopril—systemic scleroderma	0.000427	0.000922	CcSEcCtD
Trazodone—Vomiting—Captopril—systemic scleroderma	0.000427	0.000922	CcSEcCtD
Trazodone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000425	0.000918	CcSEcCtD
Trazodone—Dyspnoea—Lisinopril—systemic scleroderma	0.000424	0.000916	CcSEcCtD
Trazodone—Rash—Captopril—systemic scleroderma	0.000423	0.000914	CcSEcCtD
Trazodone—Dermatitis—Captopril—systemic scleroderma	0.000423	0.000914	CcSEcCtD
Trazodone—Somnolence—Lisinopril—systemic scleroderma	0.000423	0.000913	CcSEcCtD
Trazodone—Headache—Captopril—systemic scleroderma	0.000421	0.000909	CcSEcCtD
Trazodone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00042	0.000907	CcSEcCtD
Trazodone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000417	0.000901	CcSEcCtD
Trazodone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000417	0.000901	CcSEcCtD
Trazodone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000417	0.0009	CcSEcCtD
Trazodone—Decreased appetite—Lisinopril—systemic scleroderma	0.000413	0.000893	CcSEcCtD
Trazodone—Fatigue—Lisinopril—systemic scleroderma	0.00041	0.000885	CcSEcCtD
Trazodone—Shock—Mycophenolate mofetil—systemic scleroderma	0.00041	0.000885	CcSEcCtD
Trazodone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000408	0.000881	CcSEcCtD
Trazodone—Pain—Lisinopril—systemic scleroderma	0.000407	0.000878	CcSEcCtD
Trazodone—Constipation—Lisinopril—systemic scleroderma	0.000407	0.000878	CcSEcCtD
Trazodone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000407	0.000878	CcSEcCtD
Trazodone—Bradycardia—Prednisone—systemic scleroderma	0.000405	0.000874	CcSEcCtD
Trazodone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000403	0.00087	CcSEcCtD
Trazodone—Diarrhoea—Azathioprine—systemic scleroderma	0.000401	0.000866	CcSEcCtD
Trazodone—Nausea—Captopril—systemic scleroderma	0.000399	0.000861	CcSEcCtD
Trazodone—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000398	0.000859	CcSEcCtD
Trazodone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000397	0.000858	CcSEcCtD
Trazodone—Asthenia—Leflunomide—systemic scleroderma	0.000397	0.000858	CcSEcCtD
Trazodone—Hallucination—Prednisone—systemic scleroderma	0.000396	0.000854	CcSEcCtD
Trazodone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000392	0.000846	CcSEcCtD
Trazodone—Pruritus—Leflunomide—systemic scleroderma	0.000392	0.000846	CcSEcCtD
Trazodone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000389	0.000841	CcSEcCtD
Trazodone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000389	0.00084	CcSEcCtD
Trazodone—Dizziness—Azathioprine—systemic scleroderma	0.000387	0.000837	CcSEcCtD
Trazodone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000382	0.000826	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00038	0.00082	CcSEcCtD
Trazodone—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000379	0.000818	CcSEcCtD
Trazodone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000379	0.000818	CcSEcCtD
Trazodone—Diarrhoea—Leflunomide—systemic scleroderma	0.000379	0.000818	CcSEcCtD
Trazodone—Urticaria—Lisinopril—systemic scleroderma	0.000378	0.000816	CcSEcCtD
Trazodone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000377	0.000814	CcSEcCtD
Trazodone—Abdominal pain—Lisinopril—systemic scleroderma	0.000376	0.000812	CcSEcCtD
Trazodone—Body temperature increased—Lisinopril—systemic scleroderma	0.000376	0.000812	CcSEcCtD
Trazodone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000374	0.000808	CcSEcCtD
Trazodone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000373	0.000807	CcSEcCtD
Trazodone—Vomiting—Azathioprine—systemic scleroderma	0.000373	0.000805	CcSEcCtD
Trazodone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000371	0.000802	CcSEcCtD
Trazodone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00037	0.0008	CcSEcCtD
Trazodone—Drowsiness—Methotrexate—systemic scleroderma	0.00037	0.000799	CcSEcCtD
Trazodone—Rash—Azathioprine—systemic scleroderma	0.000369	0.000798	CcSEcCtD
Trazodone—Dermatitis—Azathioprine—systemic scleroderma	0.000369	0.000797	CcSEcCtD
Trazodone—Flushing—Prednisone—systemic scleroderma	0.000369	0.000797	CcSEcCtD
Trazodone—Headache—Azathioprine—systemic scleroderma	0.000367	0.000793	CcSEcCtD
Trazodone—Dizziness—Leflunomide—systemic scleroderma	0.000366	0.00079	CcSEcCtD
Trazodone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000362	0.000782	CcSEcCtD
Trazodone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000361	0.00078	CcSEcCtD
Trazodone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000356	0.000769	CcSEcCtD
Trazodone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000356	0.000769	CcSEcCtD
Trazodone—Arrhythmia—Prednisone—systemic scleroderma	0.000355	0.000767	CcSEcCtD
Trazodone—Sweating—Methotrexate—systemic scleroderma	0.000355	0.000766	CcSEcCtD
Trazodone—Haematuria—Methotrexate—systemic scleroderma	0.000353	0.000762	CcSEcCtD
Trazodone—Vomiting—Leflunomide—systemic scleroderma	0.000352	0.00076	CcSEcCtD
Trazodone—Alopecia—Prednisone—systemic scleroderma	0.000351	0.000759	CcSEcCtD
Trazodone—Hypersensitivity—Lisinopril—systemic scleroderma	0.00035	0.000757	CcSEcCtD
Trazodone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000349	0.000754	CcSEcCtD
Trazodone—Rash—Leflunomide—systemic scleroderma	0.000349	0.000754	CcSEcCtD
Trazodone—Dermatitis—Leflunomide—systemic scleroderma	0.000349	0.000753	CcSEcCtD
Trazodone—Nausea—Azathioprine—systemic scleroderma	0.000348	0.000752	CcSEcCtD
Trazodone—Headache—Leflunomide—systemic scleroderma	0.000347	0.000749	CcSEcCtD
Trazodone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000742	CcSEcCtD
Trazodone—Asthenia—Lisinopril—systemic scleroderma	0.000341	0.000737	CcSEcCtD
Trazodone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000341	0.000736	CcSEcCtD
Trazodone—Pruritus—Lisinopril—systemic scleroderma	0.000336	0.000727	CcSEcCtD
Trazodone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000336	0.000725	CcSEcCtD
Trazodone—Rash—Mycophenolic acid—systemic scleroderma	0.000333	0.000719	CcSEcCtD
Trazodone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000333	0.000718	CcSEcCtD
Trazodone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000715	CcSEcCtD
Trazodone—Headache—Mycophenolic acid—systemic scleroderma	0.000331	0.000714	CcSEcCtD
Trazodone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000329	0.000711	CcSEcCtD
Trazodone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000329	0.000711	CcSEcCtD
Trazodone—Nausea—Leflunomide—systemic scleroderma	0.000329	0.00071	CcSEcCtD
Trazodone—Vision blurred—Prednisone—systemic scleroderma	0.000326	0.000704	CcSEcCtD
Trazodone—Diarrhoea—Lisinopril—systemic scleroderma	0.000325	0.000703	CcSEcCtD
Trazodone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000321	0.000693	CcSEcCtD
Trazodone—Visual impairment—Methotrexate—systemic scleroderma	0.00032	0.000691	CcSEcCtD
Trazodone—Anaemia—Prednisone—systemic scleroderma	0.00032	0.000691	CcSEcCtD
Trazodone—Agitation—Prednisone—systemic scleroderma	0.000318	0.000687	CcSEcCtD
Trazodone—Dizziness—Lisinopril—systemic scleroderma	0.000314	0.000679	CcSEcCtD
Trazodone—Nausea—Mycophenolic acid—systemic scleroderma	0.000314	0.000677	CcSEcCtD
Trazodone—Malaise—Prednisone—systemic scleroderma	0.000312	0.000674	CcSEcCtD
Trazodone—Vertigo—Prednisone—systemic scleroderma	0.000311	0.000671	CcSEcCtD
Trazodone—Syncope—Prednisone—systemic scleroderma	0.00031	0.00067	CcSEcCtD
Trazodone—Tinnitus—Methotrexate—systemic scleroderma	0.00031	0.000669	CcSEcCtD
Trazodone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000663	CcSEcCtD
Trazodone—Loss of consciousness—Prednisone—systemic scleroderma	0.000304	0.000657	CcSEcCtD
Trazodone—Vomiting—Lisinopril—systemic scleroderma	0.000302	0.000653	CcSEcCtD
Trazodone—Rash—Lisinopril—systemic scleroderma	0.0003	0.000648	CcSEcCtD
Trazodone—Dermatitis—Lisinopril—systemic scleroderma	0.0003	0.000647	CcSEcCtD
Trazodone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000299	0.000646	CcSEcCtD
Trazodone—Hypertension—Prednisone—systemic scleroderma	0.000299	0.000645	CcSEcCtD
Trazodone—Chills—Methotrexate—systemic scleroderma	0.000298	0.000644	CcSEcCtD
Trazodone—Headache—Lisinopril—systemic scleroderma	0.000298	0.000643	CcSEcCtD
Trazodone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000295	0.000637	CcSEcCtD
Trazodone—Myalgia—Prednisone—systemic scleroderma	0.000295	0.000636	CcSEcCtD
Trazodone—Arthralgia—Prednisone—systemic scleroderma	0.000295	0.000636	CcSEcCtD
Trazodone—Anxiety—Prednisone—systemic scleroderma	0.000294	0.000634	CcSEcCtD
Trazodone—Alopecia—Methotrexate—systemic scleroderma	0.000294	0.000634	CcSEcCtD
Trazodone—Discomfort—Prednisone—systemic scleroderma	0.000291	0.000629	CcSEcCtD
Trazodone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000616	CcSEcCtD
Trazodone—Dysgeusia—Methotrexate—systemic scleroderma	0.000283	0.000612	CcSEcCtD
Trazodone—Nausea—Lisinopril—systemic scleroderma	0.000282	0.00061	CcSEcCtD
Trazodone—Oedema—Prednisone—systemic scleroderma	0.000282	0.00061	CcSEcCtD
Trazodone—Back pain—Methotrexate—systemic scleroderma	0.00028	0.000604	CcSEcCtD
Trazodone—Shock—Prednisone—systemic scleroderma	0.000278	0.0006	CcSEcCtD
Trazodone—Tachycardia—Prednisone—systemic scleroderma	0.000276	0.000595	CcSEcCtD
Trazodone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000276	0.000595	CcSEcCtD
Trazodone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000273	0.00059	CcSEcCtD
Trazodone—Vision blurred—Methotrexate—systemic scleroderma	0.000273	0.000589	CcSEcCtD
Trazodone—Anorexia—Prednisone—systemic scleroderma	0.000269	0.000581	CcSEcCtD
Trazodone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000268	0.00058	CcSEcCtD
Trazodone—Anaemia—Methotrexate—systemic scleroderma	0.000267	0.000577	CcSEcCtD
Trazodone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000572	CcSEcCtD
Trazodone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000567	CcSEcCtD
Trazodone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000567	CcSEcCtD
Trazodone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000564	CcSEcCtD
Trazodone—Malaise—Methotrexate—systemic scleroderma	0.000261	0.000563	CcSEcCtD
Trazodone—Vertigo—Methotrexate—systemic scleroderma	0.00026	0.000561	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000257	0.000556	CcSEcCtD
Trazodone—Insomnia—Prednisone—systemic scleroderma	0.000255	0.000552	CcSEcCtD
Trazodone—Paraesthesia—Prednisone—systemic scleroderma	0.000254	0.000548	CcSEcCtD
Trazodone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000534	CcSEcCtD
Trazodone—Myalgia—Methotrexate—systemic scleroderma	0.000246	0.000532	CcSEcCtD
Trazodone—Chest pain—Methotrexate—systemic scleroderma	0.000246	0.000532	CcSEcCtD
Trazodone—Arthralgia—Methotrexate—systemic scleroderma	0.000246	0.000532	CcSEcCtD
Trazodone—Decreased appetite—Prednisone—systemic scleroderma	0.000245	0.00053	CcSEcCtD
Trazodone—Fatigue—Prednisone—systemic scleroderma	0.000243	0.000526	CcSEcCtD
Trazodone—Discomfort—Methotrexate—systemic scleroderma	0.000243	0.000525	CcSEcCtD
Trazodone—Constipation—Prednisone—systemic scleroderma	0.000241	0.000522	CcSEcCtD
Trazodone—Confusional state—Methotrexate—systemic scleroderma	0.000238	0.000514	CcSEcCtD
Trazodone—Feeling abnormal—Prednisone—systemic scleroderma	0.000233	0.000503	CcSEcCtD
Trazodone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000231	0.000499	CcSEcCtD
Trazodone—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000228	0.000493	CcSEcCtD
Trazodone—Anorexia—Methotrexate—systemic scleroderma	0.000225	0.000486	CcSEcCtD
Trazodone—Urticaria—Prednisone—systemic scleroderma	0.000224	0.000485	CcSEcCtD
Trazodone—Abdominal pain—Prednisone—systemic scleroderma	0.000223	0.000482	CcSEcCtD
Trazodone—Body temperature increased—Prednisone—systemic scleroderma	0.000223	0.000482	CcSEcCtD
Trazodone—Hypotension—Methotrexate—systemic scleroderma	0.000221	0.000476	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000215	0.000464	CcSEcCtD
Trazodone—Insomnia—Methotrexate—systemic scleroderma	0.000213	0.000461	CcSEcCtD
Trazodone—Paraesthesia—Methotrexate—systemic scleroderma	0.000212	0.000458	CcSEcCtD
Trazodone—Dyspnoea—Methotrexate—systemic scleroderma	0.00021	0.000454	CcSEcCtD
Trazodone—Somnolence—Methotrexate—systemic scleroderma	0.00021	0.000453	CcSEcCtD
Trazodone—Hypersensitivity—Prednisone—systemic scleroderma	0.000208	0.000449	CcSEcCtD
Trazodone—Decreased appetite—Methotrexate—systemic scleroderma	0.000205	0.000443	CcSEcCtD
Trazodone—Fatigue—Methotrexate—systemic scleroderma	0.000203	0.000439	CcSEcCtD
Trazodone—Asthenia—Prednisone—systemic scleroderma	0.000203	0.000438	CcSEcCtD
Trazodone—Pain—Methotrexate—systemic scleroderma	0.000202	0.000436	CcSEcCtD
Trazodone—Pruritus—Prednisone—systemic scleroderma	0.0002	0.000432	CcSEcCtD
Trazodone—Feeling abnormal—Methotrexate—systemic scleroderma	0.000194	0.00042	CcSEcCtD
Trazodone—Diarrhoea—Prednisone—systemic scleroderma	0.000193	0.000417	CcSEcCtD
Trazodone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000193	0.000417	CcSEcCtD
Trazodone—Urticaria—Methotrexate—systemic scleroderma	0.000187	0.000405	CcSEcCtD
Trazodone—Dizziness—Prednisone—systemic scleroderma	0.000187	0.000403	CcSEcCtD
Trazodone—Body temperature increased—Methotrexate—systemic scleroderma	0.000187	0.000403	CcSEcCtD
Trazodone—Abdominal pain—Methotrexate—systemic scleroderma	0.000187	0.000403	CcSEcCtD
Trazodone—Vomiting—Prednisone—systemic scleroderma	0.00018	0.000388	CcSEcCtD
Trazodone—Rash—Prednisone—systemic scleroderma	0.000178	0.000385	CcSEcCtD
Trazodone—Dermatitis—Prednisone—systemic scleroderma	0.000178	0.000384	CcSEcCtD
Trazodone—Headache—Prednisone—systemic scleroderma	0.000177	0.000382	CcSEcCtD
Trazodone—Hypersensitivity—Methotrexate—systemic scleroderma	0.000174	0.000376	CcSEcCtD
Trazodone—Asthenia—Methotrexate—systemic scleroderma	0.000169	0.000366	CcSEcCtD
Trazodone—Nausea—Prednisone—systemic scleroderma	0.000168	0.000362	CcSEcCtD
Trazodone—Pruritus—Methotrexate—systemic scleroderma	0.000167	0.000361	CcSEcCtD
Trazodone—Diarrhoea—Methotrexate—systemic scleroderma	0.000161	0.000349	CcSEcCtD
Trazodone—Dizziness—Methotrexate—systemic scleroderma	0.000156	0.000337	CcSEcCtD
Trazodone—Vomiting—Methotrexate—systemic scleroderma	0.00015	0.000324	CcSEcCtD
Trazodone—Rash—Methotrexate—systemic scleroderma	0.000149	0.000321	CcSEcCtD
Trazodone—Dermatitis—Methotrexate—systemic scleroderma	0.000149	0.000321	CcSEcCtD
Trazodone—Headache—Methotrexate—systemic scleroderma	0.000148	0.000319	CcSEcCtD
Trazodone—Nausea—Methotrexate—systemic scleroderma	0.00014	0.000303	CcSEcCtD
